Sponsor Pipeline

Kestrel Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07458347 A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors… KRAS-mutant Non-small Cell Lung Cancer (NSCLC) Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1)
Get alerts when Kestrel Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free